Condensed Interim Consolidated Financial Statements (unaudited) Oncolytics Biotech Inc. For the three months ended March 31, 2024 ® | --- | --- | --- | --- | --- | |-------------------------------------------------------------------------------------------------------------------------------------------|-------|------------------|-------|---------------------| | As at \nAssets | | March 31, 2024 | | December 31, 2023 | | Current assets | | | | | | Cash and cash equivalents (note 4) | $| 29,603 |$ | 34,912 ...